SCHEMBL12033740

SCHEMBL12033740

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-n4c5ccc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)cc5c5cc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)ccc54)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ NTSR1 P30989 1/20 0.35
▸ NR4A2 P43354 1/20 0.35
▸ RXRA P19793 1/20 0.34
▸ ATM Q13315 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ EGLN1 Q9GZT9 2/20 0.34
▸ RAC2 P15153 1/20 0.34
▸ RAC3 P60763 1/20 0.34
▸ CDC42 P60953 1/20 0.34
▸ RAC1 P63000 1/20 0.34
▸ LDHA P00338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12033586 1.00 NR3C1 (0.39) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL11998171 0.97 L3MBTL1 (0.39) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL12033591 0.96 ATM (0.41) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL12033748 0.96 ATM (0.41) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL12033843 0.96 ATM (0.41) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL12033836 0.96 ATM (0.41) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL16689516 0.96 ATM (0.41) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL11998256 0.95 NR3C1 (0.36) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL17297429 0.94 NR3C1 (0.40) NR3C1MEN1KMT2AALDH1A1MAPT
SCHEMBL15910200 0.94 NR3C1 (0.40) NR3C1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-12-22 — — US disclosed
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME ARL1, MCOLN2, NAT1 NR3C1 495/4885MEN1 813/4885KMT2A 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback